Xilio Therapeutics, Inc. (XLO) Net margin 2024–2025
Xilio Therapeutics, Inc. (XLO) net profit margin by fiscal year — reported net income divided by reported revenue.
-80.1%FY2025 · since FY2024: -918.0% → -80.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -80.1% | +838.0 pp |
| FY2024 | -918.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice